Topiramate for essential tremor.
CONCLUSIONS: This systematic review highlighted the presence of limited data and very low to low quality evidence to support the apparent efficacy and the occurrence of treatment-limiting AEs in people with ET treated with topiramate. Further research to assess topiramate efficacy and safety on ET is needed.
PMID: 28409827 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: Journals (General) Authors: Bruno E, Nicoletti A, Quattrocchi G, Allegra R, Filippini G, Colosimo C, Zappia M Tags: Cochrane Database Syst Rev Source Type: research
More News: Allegra | Clinical Trials | Conferences | Databases & Libraries | Disability | General Medicine | Inderal | International Medicine & Public Health | Neurology | Study | Topamax | Weight Loss | WHO